Hidesaku Asakura Selected Research

Tranexamic Acid (AMCA)

1/2022	Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.
9/2021	Blue Rubber Bleb Nevus Syndrome Complicated by Enhanced-Fibrinolytic-Type DIC: A Case Report.
1/2021	Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
10/2020	Consideration of Tranexamic Acid Administration to COVID-19 Patients.
4/2020	Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acid.
12/2007	Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
11/2005	Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid.
9/2005	Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.
10/2004	Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
6/2004	Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidesaku Asakura Research Topics

Disease

51	Disseminated Intravascular Coagulation 03/2022 - 01/2002
23	Hemorrhage 03/2022 - 06/2002
19	Thrombosis (Thrombus) 03/2022 - 09/2003
8	COVID-19 01/2022 - 01/2020
7	Sepsis (Septicemia) 01/2019 - 01/2004
6	Aortic Aneurysm (Aneurysm, Aortic) 01/2022 - 09/2005
6	Neoplasms (Cancer) 01/2020 - 03/2004
5	Acute Promyelocytic Leukemia 04/2016 - 09/2003
4	Thrombocytopenia (Thrombopenia) 03/2022 - 09/2005
4	Infections 01/2020 - 01/2005
3	Inflammation (Inflammations) 08/2021 - 10/2006
3	Pulmonary Embolism 01/2021 - 07/2014
3	Hemophilia A (Haemophilia) 09/2019 - 01/2010
3	Venous Thrombosis (Deep-Vein Thrombosis) 03/2017 - 10/2011
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2015 - 04/2004
3	Hematologic Neoplasms (Hematological Malignancy) 10/2014 - 12/2007
3	Abdominal Aortic Aneurysm 10/2009 - 09/2005
3	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2006 - 12/2005
2	Cytokine Release Syndrome 10/2021 - 01/2021
2	Hemangioma (Angioma) 09/2021 - 11/2005
2	Hyperkalemia 01/2021 - 02/2005
2	Disease Progression 01/2021 - 01/2020
2	Immunoglobulin Light-chain Amyloidosis 04/2020 - 09/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2018
2	Thrombotic Microangiopathies 01/2019 - 05/2009
2	Liver Failure 01/2016 - 10/2011
2	Disease Susceptibility (Diathesis) 08/2015 - 01/2010
2	Myocardial Infarction 07/2014 - 09/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2014 - 08/2006
2	Lymphoma (Lymphomas) 03/2014 - 01/2006
2	Wounds and Injuries (Trauma) 06/2013 - 09/2003
2	Aneurysm (Aneurysms) 10/2009 - 01/2008
2	Leukemia 12/2007 - 12/2005
2	Bronchiolitis Obliterans Syndrome 02/2006 - 01/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2005 - 03/2004
1	Multiple Organ Failure (MODS) 10/2021
1	Blue rubber bleb nevus syndrome 09/2021
1	Vascular Malformations 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Pancreatitis 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 06/2020
1	Periodontitis 06/2020

Drug/Important Bio-Agent (IBA)

48	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 06/2002
12	AnticoagulantsIBA 01/2022 - 01/2010
11	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 06/2002
11	LipopolysaccharidesIBA 01/2022 - 01/2002
10	Tranexamic Acid (AMCA)FDA Link 01/2022 - 06/2004
10	Hemostatics (Antihemorrhagics)IBA 01/2022 - 01/2002
9	Thromboplastin (Tissue Factor)IBA 08/2021 - 01/2002
8	AntithrombinsIBA 01/2021 - 09/2012
5	fibrin fragment D (D-dimer)IBA 03/2022 - 05/2004
4	Antifibrinolytic Agents (Antifibrinolytics)IBA 09/2021 - 09/2005
4	FibrinIBA 08/2021 - 10/2004
4	ThrombomodulinIBA 01/2019 - 03/2014
3	Fibrinogen (Factor I)FDA Link 03/2022 - 04/2003
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 10/2004
3	nafamostatIBA 01/2022 - 01/2020
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2021 - 10/2002
3	Factor X (Stuart Factor)IBA 01/2020 - 09/2012
3	CytokinesIBA 10/2008 - 09/2006
3	antithrombin III-protease complexIBA 10/2006 - 01/2002
3	Endothelins (Endothelin)IBA 04/2005 - 10/2002
2	VaccinesIBA 03/2022 - 01/2022
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 07/2021 - 01/2004
2	Thrombin FDA Link 07/2021 - 11/2016
2	prothrombin complex concentrates (PPSB)IBA 01/2020 - 01/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 09/2011
2	RivaroxabanIBA 11/2017 - 07/2014
2	Warfarin (Coumadin)FDA LinkGeneric 11/2017 - 10/2011
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2015 - 01/2010
2	Factor VII (Proconvertin)IBA 03/2012 - 01/2002
2	Annexin A2 (Annexin II)IBA 10/2009 - 01/2008
2	Inosine Triphosphate (ITP)IBA 05/2009 - 09/2006
2	danaparoid (Orgaran)FDA Link 11/2005 - 09/2005
1	Platelet Factor 4IBA 03/2022
1	COVID-19 VaccinesIBA 03/2022
1	ImmunosorbentsIBA 03/2022
1	EnzymesIBA 03/2022
1	AntibodiesIBA 03/2022
1	Erythropoietin FDA Link 01/2022
1	apixabanIBA 09/2021
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2021
1	argatroban (MPQA)FDA Link 07/2021
1	N(6)-(1-iminoethyl)lysineIBA 07/2021
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2021
1	Factor Xa InhibitorsIBA 07/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2021
1	idarucizumabIBA 06/2020
1	Factor XIII (Coagulation Factor XIII)IBA 06/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 04/2020

Therapy/Procedure

14	Therapeutics 01/2022 - 09/2005
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2004
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2007 - 04/2004
3	Stem Cell Transplantation 12/2005 - 03/2004
1	Sclerotherapy 09/2021
1	Extracorporeal Membrane Oxygenation 12/2020